Clinical trial
Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
NCT00002781 · Beth Israel Deaconess Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00002781 |
|---|---|
| Title | Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma |
| Official title | PROCEDURES FOR BNCT PHASE-I STUDY OF MELANOMA IN THE EXTREMITIES |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug |
| Interventions | boronophenylalanine-fructose complex |
| Enrollment | 15 |
| Start date | Apr 1, 1996 |
| First posted | Sep 2, 2004 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: